The global pet cancer therapeutics market size is calculated at USD 493.01 million in 2025 and is forecasted to reach around USD 1,150.70 million by 2034, accelerating at a CAGR of 9.89% from 2025 to 2034. The North America pet cancer therapeutics market size surpassed USD 318.10 billion in 2024 and is expanding at a CAGR of AA% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pet Cancer Therapeutics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pet Cancer Therapeutics Market, by Therapy
8.1.1. Chemotherapy
8.1.1.1. Market Revenue and Forecast
8.1.2. Immunotherapy
8.1.2.1. Market Revenue and Forecast
8.1.3. Targeted therapy
8.1.3.1. Market Revenue and Forecast
8.1.4. Combination therapy
8.1.4.1. Market Revenue and Forecast
8.1.5. Radiation therapy
8.1.5.1. Market Revenue and Forecast
8.1.6. Surgery
8.1.6.1. Market Revenue and Forecast
9.1. Pet Cancer Therapeutics Market, by Applications
9.1.1. Mast Cell Cancer
9.1.1.1. Market Revenue and Forecast
9.1.2. Lymphoma
9.1.2.1. Market Revenue and Forecast
9.1.3. Melanoma
9.1.3.1. Market Revenue and Forecast
9.1.4. Mammary and Squamous Cell Cancer
9.1.4.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Therapy
10.1.2. Market Revenue and Forecast, by Applications
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Therapy
10.1.3.2. Market Revenue and Forecast, by Applications
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Therapy
10.1.4.2. Market Revenue and Forecast, by Applications
10.2. Europe
10.2.1. Market Revenue and Forecast, by Therapy
10.2.2. Market Revenue and Forecast, by Applications
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Therapy
10.2.3.2. Market Revenue and Forecast, by Applications
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Therapy
10.2.4.2. Market Revenue and Forecast, by Applications
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Therapy
10.2.5.2. Market Revenue and Forecast, by Applications
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Therapy
10.2.6.2. Market Revenue and Forecast, by Applications
10.3. APAC
10.3.1. Market Revenue and Forecast, by Therapy
10.3.2. Market Revenue and Forecast, by Applications
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Therapy
10.3.3.2. Market Revenue and Forecast, by Applications
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Therapy
10.3.4.2. Market Revenue and Forecast, by Applications
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Therapy
10.3.5.2. Market Revenue and Forecast, by Applications
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Therapy
10.3.6.2. Market Revenue and Forecast, by Applications
10.4. MEA
10.4.1. Market Revenue and Forecast, by Therapy
10.4.2. Market Revenue and Forecast, by Applications
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Therapy
10.4.3.2. Market Revenue and Forecast, by Applications
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Therapy
10.4.4.2. Market Revenue and Forecast, by Applications
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Therapy
10.4.5.2. Market Revenue and Forecast, by Applications
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Therapy
10.4.6.2. Market Revenue and Forecast, by Applications
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Therapy
10.5.2. Market Revenue and Forecast, by Applications
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Therapy
10.5.3.2. Market Revenue and Forecast, by Applications
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Therapy
10.5.4.2. Market Revenue and Forecast, by Applications
11.1. AB Science
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Anivive Lifesciences
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Elanco Animal Health
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ELIAS Animal Health
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Merial Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. NovaVive
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Qbiotics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Zoetis Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample